These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12048585)

  • 1. [Survival analysis techniques].
    Bustamante-Teixeira MT; Faerstein E; Latorre Mdo R
    Cad Saude Publica; 2002; 18(3):579-94. PubMed ID: 12048585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Just Another Statistic".
    Machtay M; Glatstein E
    Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival analysis techniques in clinical research.
    Myers J
    J Ky Med Assoc; 2007 Nov; 105(11):545-50. PubMed ID: 18183806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A generalized log-rank-type test for comparing survivals with doubly interval-censored data.
    Kim J; Kim YJ; Nam CM
    Biom J; 2009 Aug; 51(4):689-96. PubMed ID: 19650058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Issues in applied statistics for public health bioterrorism surveillance using multiple data streams: research needs.
    Rolka H; Burkom H; Cooper GF; Kulldorff M; Madigan D; Wong WK
    Stat Med; 2007 Apr; 26(8):1834-56. PubMed ID: 17221940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of progression-free survival data using a discrete time survival model that incorporates measurements with and without diagnostic error.
    Hunsberger S; Albert PS; Dodd L
    Clin Trials; 2010 Dec; 7(6):634-42. PubMed ID: 21109582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in clinical cancer trials.
    Estey E
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2591-3. PubMed ID: 9815662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing phase II studies in cancer with time-to-event endpoints.
    Owzar K; Jung SH
    Clin Trials; 2008; 5(3):209-21. PubMed ID: 18559409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interpreting trends in cancer patient survival.
    Dickman PW; Adami HO
    J Intern Med; 2006 Aug; 260(2):103-17. PubMed ID: 16882274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On estimation in relative survival.
    Perme MP; Stare J; Estève J
    Biometrics; 2012 Mar; 68(1):113-20. PubMed ID: 21689081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Armitage lecture 2010: Understanding treatment effects: the value of integrating longitudinal data and survival analysis.
    Aalen OO
    Stat Med; 2012 Aug; 31(18):1903-17. PubMed ID: 22438240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When are "positive" clinical trials in oncology truly positive?
    Ocana A; Tannock IF
    J Natl Cancer Inst; 2011 Jan; 103(1):16-20. PubMed ID: 21131576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysing sequential events in clinical trials.
    Salter A; Raab G; Day S
    Clin Trials; 2006; 3(5):421-30. PubMed ID: 17060216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of a composite endpoint with longitudinal and time-to-event data.
    Tseng CH; Wong WK
    Stat Med; 2011 Apr; 30(9):1018-27. PubMed ID: 21341299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immortal person-time in studies of cancer outcomes.
    Lash TL; Cole SR
    J Clin Oncol; 2009 Aug; 27(23):e55-6. PubMed ID: 19597013
    [No Abstract]   [Full Text] [Related]  

  • 17. [Establishing criteria for survival of oncology patients on a regional level].
    Merabishvili VM; Tsvetkova TL; Lebedev VV; Popova SP; Reznikova TV; Anal'kova IV
    Vopr Onkol; 2000; 46(2):149-52. PubMed ID: 10853410
    [No Abstract]   [Full Text] [Related]  

  • 18. [Problems of statistical evaluation of survival time studies].
    Schumacher M
    Z Orthop Ihre Grenzgeb; 1989; 127(4):428-32. PubMed ID: 2815946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interpretation of population-based cancer survival data.
    Black RJ; Sankaranarayanan R; Parkin DM
    IARC Sci Publ; 1998; (145):13-7. PubMed ID: 10194623
    [No Abstract]   [Full Text] [Related]  

  • 20. Statistical analysis of clinical trials.
    Wassertheil-Smoller S; Kim MY
    Semin Nucl Med; 2010 Sep; 40(5):357-63. PubMed ID: 20674595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.